Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Approach to the patient with chronic hepatitis C virus infection.

    Herrine SK.

    Ann Intern Med. 2002 May 21;136(10):747-57.PMID: 12020143 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    NIH Consensus Statement on Management of Hepatitis C: 2002.

    [No authors listed]

    NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. Review.PMID: 14768714 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

    Seeff LB, Hoofnagle JH.

    Clin Liver Dis. 2003 Feb;7(1):261-87. Review.PMID: 12691470 [PubMed - indexed for MEDLINE]Related articles

    4.

    Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team.

    N Engl J Med. 2004 Jul 29;351(5):451-9.PMID: 15282352 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.

    Salomon JA, Weinstein MC, Hammitt JK, Goldie SJ.

    JAMA. 2003 Jul 9;290(2):228-37.PMID: 12851278 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.

    Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT; APRICOT Study Group.

    N Engl J Med. 2004 Jul 29;351(5):438-50.PMID: 15282351 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients.

    Silva C, Gonçales NS, Pereira JS, Escanhoela CA, Pavan MH, Gonçales FL Jr.

    Braz J Infect Dis. 2004 Dec;8(6):431-9. Epub 2005 May 9.PMID: 15880234 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.

    Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team.

    JAMA. 2004 Dec 15;292(23):2839-48.PMID: 15598915 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Chronic hepatitis C virus infection in renal transplant: treatment and outcome.

    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.

    Clin Transplant. 2006 Nov-Dec;20(6):677-83.PMID: 17100715 [PubMed - indexed for MEDLINE]Related articles

    10.

    Ribavirin in the treatment of hepatitis C.

    Abonyi ME, Lakatos PL.

    Anticancer Res. 2005 Mar-Apr;25(2B):1315-20.PMID: 15865084 [PubMed - indexed for MEDLINE]Related articles

    11.

    Management of patients with chronic hepatitis C infection.

    Herrine SK, Rossi S, Navarro VJ.

    Clin Exp Med. 2006 Mar;6(1):20-6. Review.PMID: 16550340 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hepatitis C virus transmission in family members of Egyptian patients with HCV related chronic liver disease.

    Madwar MA, El-Gindy I, Fahmy HM, Shoeb NM, Massoud BA.

    J Egypt Public Health Assoc. 1999;74(3-4):313-32.PMID: 17219873 [PubMed - indexed for MEDLINE]Related articles

    13.

    Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C.

    Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, Trabaud MA, Chevallier P, Chevallier M, Zoulim F, Trépo C.

    J Med Virol. 2007 Aug;79(8):1075-81.PMID: 17596829 [PubMed - indexed for MEDLINE]Related articles

    14.

    Management of hepatitis C.

    Smith C.

    Minn Med. 2003 Jun;86(6):53-6.PMID: 12834215 [PubMed - indexed for MEDLINE]Related articles

    15.

    Therapy of chronic hepatitis C virus infection in HIV co-infected people.

    Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

    Curr Pharm Des. 2004;10(17):2111-22. Review.PMID: 15279550 [PubMed - indexed for MEDLINE]Related articles

    16.

    Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.

    Antúnez I, Aponte N, Fernández-Carbia A, Rodríguez-Perez F, Toro DH.

    P R Health Sci J. 2004 Jun;23(2 Suppl):57-60.PMID: 16929588 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies.

    Soriano V, Maida I, Núñez M, García-Samaniego J, Barreiro P, Martín-Carbonero L, González-Lahoz J.

    Antivir Ther. 2004 Dec;9(6):987-92.PMID: 15651757 [PubMed - indexed for MEDLINE]Related articles

    18.

    Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy.

    Bräu N.

    J Antimicrob Chemother. 2005 Dec;56(6):991-5. Epub 2005 Nov 24.PMID: 16308419 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Why is there a poor response to combined therapy with interferon alfa 2b and ribavirin in patients with chronic hepatitis C?]

    Stránský J, Rýzlová M, Stríteský J, Nĕmecek V.

    Cas Lek Cesk. 2002 Jun 7;141(11):351-4. Czech. PMID: 12099059 [PubMed - indexed for MEDLINE]Related articles

    20.

    Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic.

    Kolor B.

    Pharmacotherapy. 2005 Sep;25(9):1230-41.PMID: 16164396 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data